Zymeworks (ZYME) Long-Term Investments (2021 - 2026)

Zymeworks (ZYME) has 6 years of Long-Term Investments data on file, last reported at $39.1 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments fell 30.55% year-over-year to $39.1 million; the trailing twelve-month figure through Mar 2026 stood at $39.1 million (down 30.55% YoY), and the FY2025 full-year result was $41.8 million, down 57.55% from the prior year.
• Long-Term Investments eased to $39.1 million in Q1 2026, from $41.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $98.4 million in Q4 2024 to a low of $886000.0 in Q3 2022.
• A 5-year average of $59.9 million and a median of $65.8 million in 2024 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments soared 10698.42% in 2023 and plunged 57.55% in 2025, its largest moves.
• Tracing ZYME's Long-Term Investments over 5 years: stood at $886000.0 in 2022, then soared by 9147.18% to $81.9 million in 2023, then advanced by 20.14% to $98.4 million in 2024, then tumbled by 57.55% to $41.8 million in 2025, then dropped by 6.39% to $39.1 million in 2026.
• Business Quant data shows ZYME's Long-Term Investments at $39.1 million in Q1 2026, $41.8 million in Q4 2025, and $47.4 million in Q3 2025.